No Data
Three key points to watch in the first half of the session - expecting a resilient market led by technology shareholders.
Three days ago, attention should be focused on the following three points during the morning trade. ■Expectation for a resilient market driven by technology stocks ■Ito En, 2Q operating profit down 15.6% to 14.3 billion yen ■Notable items from the morning session: Kawasaki Heavy Industries is recycling vehicle batteries, recovering lithium carbonate with a purity of 99.5%. ■Expectation for a resilient market driven by technology stocks. The Japanese stock market on the 3rd is expected to be in a strong consolidation phase after an initial buy, but the firmness at lower levels should be recognized. On the 2nd, the USA market saw the dow jones industrial average down by 128 dollars, and the Nasdaq...
Kawasaki Heavy Industries, dai, etc. [List of company materials from the newspaper]
*Kawasaki Heavy Industries <7012> recycles automotive batteries, recovering lithium carbonate with a purity of 99.5% (Nikkan Kogyo, page 1) - ○*Daihatsu <6622> enhances collaborative and transportation robots, strategic models expected in spring next year (Nikkan Kogyo, page 1) - ○*Shimadzu Corporation <7701> enters gene therapy, invests in Osaka University Spinoff, establishes analysis and evaluation methods, etc (Nikkan Kogyo, page 3) - ○*Resonac <4004> forms fine copper circuits, photosensitive films for AI semiconductors (Nikkan Kogyo, page 3) - ○*NTT <9432> NTT Com, research on land-based aquaculture.
Asia-Pacific High-Performance Liquid Chromatography Market Research Report 2023-2033, Competition Synopsis of Shimadzu, Hitachi, YMC CO, and JASCO - ResearchAndMarkets.com
Establishing investment analysis and evaluation methods for the startup You Medico from Osaka University, aimed at fully entering the gene therapy drug business.
Shimadzu Corporation has entered into an investment agreement with You Medico Co., Ltd. (headquartered in Osaka Prefecture, hereinafter referred to as You Medico), a contract research organization (CRO). With this investment, the company will start joint development of a "gene therapy manufacturing platform" aimed at pharmaceutical companies, contract development and manufacturing organizations (CDMO), mainland education research institutions, etc., and provide this platform domestically and internationally from December 2024. The company will support the manufacturing of gene therapy pharmaceuticals.
Pro Mao Saigo has been named Rookie of the Year on the U.S. Golf Tour.
Shimadzu's professional golfer, Mao Saigo, who belongs to the company, shone as the "Rookie of the Year" in the US Golf Tour (LPGA), where she has been participating full-time since this season. She achieved a good record of entering the top 10 in 7 out of 29 games (including 2 second places), marking the second remarkable achievement for Japanese players since Hiroshi Kobayashi in 1990 (current chairman of the Japan Ladies Professional Golf Association) after 34 years. Pro player Saigo will also challenge the LPGA in 2025. Mao Saigo Comment
Protein Sequencing Market Analysis and Forecast 2024-2033, Featuring Profiles of Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific, Shimadzu, Selvita, Bruker, Merck, Seer and More